Total reported value
$2.1B
Reporting period: 2026-03-31 · Number of holdings: 6
GILEAD SCIENCES, INC. disclosed 6 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $2.1B and a quarterly turnover rate of 23.9%.
Browse other institutions with $1B to $10B AUMBrowse other institutions starting with "G"
Add ACLXGBX
0.0% $333.5M
Trim RCUS
0.0% -$70.1M
Trim LKFT
0.0% -$49.4M
Trim ASMB
0.0% -$28.2M
Trim KYTX
0.0% -$3.2M
Trim 98422T100
-92.9% -$359.5K
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx INC | Stock-Other | 36.44% | +13.80% | — | |
| 2 | RCUS | Arcus Biosciences INC | Stock-Other | 32.05% | -6.64% | — | |
| 3 | LKFT | Lakefront Biotherapeutic-adr | Stock-Other | 23.67% | -4.78% | — | |
| 4 | ASMB | Assembly Biosciences INC | Stock-Other | 5.90% | -2.02% | — | |
| 5 | KYTX | Kyverna Therapeutics INC | Stock-Other | 1.68% | -0.32% | — | |
| 6 | ✓ | Xilio Therapeutics INC | Stock-Other | 0.26% | -0.04% | -92.86% |
Performance for Q3 2026
—
Performance Last 4 Quarters
—
Based on 0 months of available history
Based on 31% of reported portfolio value with available pricing
Not enough sector-mapped data yet
Gilead Sciences, INC.'s most significant position changes for 2026-03-31: Trim: Xilio Therapeutics INC — shares -92.86%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ACLXGBX | Arcellx INC | +13.8% | — | Unchanged |
| 2 | ✓ | Xilio Therapeutics INC | 0% | -92.86% | Trim |
| 3 | KYTX | Kyverna Therapeutics INC | -0.3% | — | Unchanged |
| 4 | ASMB | Assembly Biosciences INC | -2% | — | Unchanged |
| 5 | LKFT | Lakefront Biotherapeutic-adr | -4.8% | — | Unchanged |
| 6 | RCUS | Arcus Biosciences INC | -6.6% | — | Unchanged |
Institutions with a similar AUM
CIK 0001085393
Total reported value
$2.1B
108 stks
2026-03-31
AUM within 0.1% of this institution
CIK 0001661462
Total reported value
$2.1B
1 stks
2023-12-31
Stale — no recent filing
AUM within 0.1% of this institution
CIK 0001454138
Total reported value
$2.1B
18 stks
2026-06-30
AUM within 0.2% of this institution
Institutions with overlapping top holdings
CIK 0001143261
Total reported value
$187.1M
81 stks
2026-03-31
1 of the top 5 holdings overlap, including Arcellx INC
CIK 0001232621
Total reported value
$2.0B
51 stks
2026-03-31
1 of the top 5 holdings overlap, including Lakefront Biotherapeutic-adr
CIK 0001388551
Total reported value
$4.0M
7 stks
2026-03-31
1 of the top 5 holdings overlap, including Kyverna Therapeutics INC